常乐康、茵栀黄联合治疗新生儿黄疸临床观察  

Clinical observation of Changlekang combined with Yinzhihuang in the treatment of neonatal jaundice

作　　者：周莉[1] 迪拉热木[1] Zhou Li;Dila Remu

机构地区：[1]新疆伊犁州友谊医院儿科,835000

出　　处：《中国社区医师》2017年第9期91-91,93,共2页Chinese Community Doctors

摘　　要：目的:观察常乐康、茵栀黄颗粒联合治疗新生儿黄疸的临床疗效。方法:将120例新生儿黄疸患者随机平均分为两组,对照组常规给予蓝光照射治疗,观察组在此基础上口服常乐康和茵栀黄颗粒。观察两组治疗后患儿胆红素下降情况、住院时间及治疗效果。结果:观察组患儿胆红素下降幅度明显高于对照组,住院时间比对照组短,治疗总有效率(94.6%)高于对照组(80.0%),差异均具有统计学意义(P<0.05)。结论:常乐康、茵栀黄联合治疗新生儿黄疸简单有效,住院时间短。Objective:To observe the clinical effect of Changlekang combined with Yinzhihuang in the treatment of neonatal jaundice.Methods:120cases of neonatal jaundice were randomly divided into two groups on average.The control group was treated with blue light irradiation.The observation group was treated with Changle Kang and Yinzhihuang granules on the basis of the control group.We compared the decline of bilirubin,hospitalization time and treatment effect of patients in the two groups after treatment.Results:The decrease of bilirubin in the observation group was significantly higher than that in the control group,with short hospitalization time;the total effective rate(94.6%)was higher than the control group(80%);the differences were statistically significant(P<0.05).Conclusion:Changlekang and Yinzhihuang combined treatment of neonatal jaundice is simple and effective,with short hospitalization time.

关 键 词：常乐康 茵栀黄 新生儿黄疸 

分 类 号：R722.17[医药卫生—儿科]